Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| N-[[4-[[(4-Aminoquinazolin-2-yl)amino]methyl]cyclohexyl]methyl]naphthalene-1-sulfonamide | IC50 | 1.3 [1], 2.9 [2] | |
| MK-0557 | IC50 | 1.26 [1], 1.3 [2] | |
| MK-0557 | Ki | 1.6 [1] | |
| 9-(2-Hydroxy-4,4-dimethyl-6-oxo-1-cyclohexen-1-yl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-one | IC50 | 61.0 [1] | |
| 9-(2-Hydroxy-4,4-dimethyl-6-oxo-1-cyclohexen-1-yl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-one | Ki | 33.0 [1] | |
MLA | "Quest Database™ Neuropeptide Y receptor type 5 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 30 Dec. 2025, https://www.aatbio.com/data-sets/neuropeptide-y-receptor-type-5-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 30). Quest Database™ Neuropeptide Y receptor type 5 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/neuropeptide-y-receptor-type-5-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |